Lauren Van Wassenhove, PhD, ISMPP CMPP’s Post

The pace of trial recruitment for Alzheimer's disease is lagging behind scientific advancements, particularly in early-phase clinical trials. Parexel experts Lydia Morris and Jakki James emphasize the significance of listening to and engaging with the concerns of prospective trial participants. They also propose innovative solutions for earlier diagnoses and the identification of surrogates for patients. Read the latest blog from our neurosciences trial series here: https://lnkd.in/g3kG8jj3 Message me if you would like to learn more about how Parexel is increasing efficiencies in clinical trial participation! #Alzheimers #EarlyPhase #ClinicalResearch #PatientsFirst

To view or add a comment, sign in

Explore topics